OF THE
TIMES

The killing of a senior Russian military official, Igor Kirillov, in Moscow on Tuesday was a "special operation" by Ukraine's SBU security service, a source inside the agency told AFP.
Kirillov is the most senior Russian army official to be targeted on Russian territory, killed with his assistant when an explosive device attached to a scooter went off outside an apartment building in south-eastern Moscow.
"The liquidation of Lieutenant General Igor Kirillov, chief of the Russian Armed Forces' radiation, chemical and biological defence troops is a special operation by the SBU," the source said.
"Kirillov was a war criminal and an absolutely legitimate target, as he gave orders to use banned chemical weapons against the Ukrainian military," it said.
A straight-up lie. Russia destroyed the last of its stockpiles in 2017, per the 1993 Chemical Weapons Convention. The U.S. of course, reneged on the agreement.
- Russia destroys over 75% of its chemical weapons stockpile
- Russia dismantles 90% of its chemical weapons stockpile
- Russia destroys last chemical weapons ahead of schedule - but US is long overdue to destroy its own
Kirillov was on Monday charged in absentia by Ukrainian authorities over alleged war crimes following an investigation by the SBU.
In October, he had been sanctioned by the UK over the suspected use of chemical weapons in Ukraine.
"Such an inglorious end awaits all those who kill Ukrainians. Retribution for war crimes is inevitable," the SBU source said.
It confirmed Kirillov was killed when "a scooter with explosives" detonated as he entered the building on Ryazansky Avenue in Moscow.


Comment: This development has received little media attention in the West, naturally, because it happened in Russia, so we looked into the basis of the claim.
The Russian developers are turning cancerous mutations into antigens so that the immune system can attack them better. This technique has apparently worked in animal studies. They're starting trials on humans with super-aggressive melanomas and small cell lung cancer, where the prognosis is already very bad. Each vaccine is individualized to the patient. They do use mRNA technology, but this might prove to be the best use for such. In the animal studies, the vaccine regressed or cured animals from metastasis and terminal cancer.
So the principle behind it is to reinforce the immune system by 'teaching' it to attack the cancer rather than 'feed' it or accept it as 'normal'.
More in this India Times report about how AI-based 'neural network computing' will be used to 'create a personalized cancer vaccine in 30 minutes'. See also the press release.